Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma
Status:
Recruiting
Trial end date:
2046-12-31
Target enrollment:
Participant gender:
Summary
The trial investigates a stage-adapted (stage IIA or IIB) de-escalation of the standard
treatments in the context of a multimodality treatment with chemo- and radiotherapy in
seminoma patients. The goal is to safely de-escalate treatment while maintaining/enhancing
efficacy, which is not a standard practice yet.